Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Leo didn't waste three years on ABSSSI. He submitted the SPA request on 2/26/2016, received a response on 4/19/2016, and continued talking to the FDA on 10/26/2016. IPIX didn't want to start Phase 3 without reaching an agreement first.

http://www.ipharminc.com/press-release-2/2016/9/19/cellceutix-submits-special-protocol-assessment-request-to-fda-for-phase-3-clinical-trial-of-brilacidin-for-abssi

http://www.ipharminc.com/press-release/2016/11/15/cellceutix-initiates-database-soft-lock-on-its-phase-2-psoriasis-clinical-trial-top-line-results-expected-in-may-additional-company-updates

http://www.ipharminc.com/press-release-2/2016/10/26/cellceutix-novel-anti-inflammatory-phase-2-drug-candidate-brilacidin-builds-momentum-across-multiple-clinical-indications

So they wasted 3 years on Absssi with still no timetable for starting.